Intelligent Bio Solutions Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在生物技術與醫療研究行業排名192/404位。機構持股佔比非常高,近一個月多位分析師給出公司評級為。最高目標價12.00。中期看,股價處於上升通道。近一個月,市場表現很強,技術面和基本面綜合得分較高,很強的走勢得到基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Intelligent Bio Solutions Inc評分
相關信息
行業排名
192 / 404
全市場排名
343 / 4582
所屬行業
生物技術與醫療研究
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
0
分析師
--
評級
12.000
目標均價
+455.56%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
Intelligent Bio Solutions Inc亮點
亮點風險
Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
公司代碼INBS
公司Intelligent Bio Solutions Inc
CEOSimeonidis (Harry)
網址https://ibs.inc/
常見問題
Intelligent Bio Solutions Inc(INBS)的當前股價是多少?
Intelligent Bio Solutions Inc(INBS)的當前股價是 6.140。
Intelligent Bio Solutions Inc 的股票代碼是什麼?
Intelligent Bio Solutions Inc的股票代碼是INBS。
Intelligent Bio Solutions Inc股票的52週最高點是多少?
Intelligent Bio Solutions Inc股票的52週最高點是27.500。
Intelligent Bio Solutions Inc股票的52週最低點是多少?
Intelligent Bio Solutions Inc股票的52週最低點是5.091。
Intelligent Bio Solutions Inc的市值是多少?
Intelligent Bio Solutions Inc的市值是55.86M。
Intelligent Bio Solutions Inc的淨利潤是多少?
Intelligent Bio Solutions Inc的淨利潤為-10.57M。
現在Intelligent Bio Solutions Inc(INBS)的股票是買入、持有還是賣出?
根據分析師評級,Intelligent Bio Solutions Inc(INBS)的總體評級為--,目標價格為12.000。
Intelligent Bio Solutions Inc(INBS)股票的每股收益(EPS TTM)是多少
Intelligent Bio Solutions Inc(INBS)股票的每股收益(EPS TTM)是-1.648。